Print Page     Close Window     

SEC Filings

S-8
SERES THERAPEUTICS, INC. filed this Form S-8 on 03/06/2019
Entire Document
 


PART I

EXPLANATORY NOTE

This Registration Statement on Form S-8 is being filed for the purpose of registering an additional 400,000 shares of the common stock of Seres Therapeutics, Inc. (the “Registrant”) to be issued pursuant to the ESPP and an additional 1,637,469 shares of the Registrant’s common stock to be issued pursuant to the Incentive Plan. A Registration Statement of the Registrant on Form S-8 relating to the same employee benefit plans is effective.

INCORPORATION BY REFERENCE OF CONTENTS OF

REGISTRATION STATEMENTS ON FORM S-8

Except as set forth below, the contents of the Registration Statements on Form S-8 (File Nos. 333-205253, 333-210171 and 333-223514) filed with the Securities and Exchange Commission, relating to the ESPP and Incentive Plan, are incorporated by reference herein.

Item 8. Exhibits.

 

Number

  

Description

  4.1    Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit  3.1 to the Registrant’s Current Report on Form 8-K (File No. 001-37456) filed on July 1, 2015)
  4.2    Amended and Restated By-Laws of the Registrant (incorporated by reference to Exhibit  3.2 to the Registrant’s Current Report on Form 8-K (File No. 001-37456) filed on July 1, 2015)
  5.1+    Opinion of Latham & Watkins LLP, counsel to the Registrant
23.1+    Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm
23.2+    Consent of Latham & Watkins LLP (included in Exhibit 5.1)
24.1+    Power of attorney (included on signature pages below)
99.1    Seres Therapeutics, Inc. 2015 Incentive Award Plan (incorporated by reference to Exhibit  10.2 to the Registrant’s Registration Statement on Form S-1 (Reg. No. 333-204484) filed on May 27, 2015)
99.2    Seres Therapeutics, Inc. 2015 Employee Stock Purchase Plan (incorporated by reference to Exhibit  10.3 to the Registrant’s Registration Statement on Form S-1 (Reg. No. 333-204484) filed on May 27, 2015)

 

+ Filed herewith


© Seres Therapeutics. All Rights Reserved.